INTRODUCTION
============

Endoscopic mucosal resection (EMR) is regarded as a safe and effective treatment for large sessile colorectal polyps (20 mm or more),[@B1] nevertheless, it remains challenging because of technical difficulties, the high risk of complications, and the potential of coexisting malignancies or local recurrence following the procedure.[@B2][@B3][@B4][@B5] A recent multicenter study showed favorable outcome success rate of 89.2% for a single session EMR; complications were observed in 7.7% of cases, including post-procedure pain in 2.1%, serositis in 1.5%, bleeding in 2.9% of patients, and perforation in 1.3% of patients.[@B6]

Regardless of the EMR technical advances, which have resulted in these favorable results, the long-term outcomes have not been elucidated, especially for large sessile colorectal polyps. The large colorectal polyp local recurrence rate following EMR has been reported to be between 5% and 45%,[@B2][@B3][@B7] although it is difficult to compare the results from these different studies because of a wide variation in the polyp size, EMR method, and follow-up interval. A recent multicenter study reported a 20.4% of local recurrence or residual tumor presence detected using surveillance colonoscopy.[@B6] In regard to the technical aspects of resection, en bloc resection of lesions is recommended because it allows for a more accurate histological assessment and reduces the risk of local recurrence.[@B8][@B9] However, in cases where difficult locations or large polyp sizes prevent en bloc resection, endoscopic piecemeal mucosal resection (EPMR) is recommended. [@B10] EPMR is regarded as a significant risk factor for local recurrence, especially in cases where 5 or more neoplasm specimens are removed.[@B11] Thus, in cases of EPMR, short interval follow-up colonoscopy is recommended, irrespective of the tumor size or macroscopic features.[@B11]

According to several current guidelines,[@B12][@B13][@B14][@B15] a repeat colonoscopy is recommended after a short interval (2-6 months) because of high rate of local recurrence and residual tumor presence, especially in patients with large sessile adenomas removed by piecemeal resection. However, this advice is based on expert opinion; there is no definitive evidence for short interval colonoscopy in such high-risk adenoma cases. Therefore, a consensus needs to be reached regarding the best surveillance colonoscopy interval following EMR for large sessile colorectal polyps. The aim of this study was to evaluate the long-term outcomes and elucidate the best surveillance colonoscopy interval following EMR of large sessile colorectal polyps.

MATERIALS AND METHODS
=====================

Patients and study protocol
---------------------------

Our colonoscopy cohort included 331 consecutive patients who received endoscopic treatment for colorectal polyps larger than 20 mm from May 2005 to November 2011 at Yonsei University College of Medicine, Seoul, Korea. Patients were included if the following polyp criteria were met: 1) sessile polyp (defined as a lesion in which the base is attached to the colon wall) or flat polyp (defined as a lesion with a thickness less than half of the maximum width); 2) equal to or greater than 20 mm in size; and 3) adenoma, carcinoma *in situ*, or intramucosal cancer indicated in the final pathological report following endoscopic resection.[@B16] We excluded patients with colorectal tumors with stalks, colorectal cancers, carcinoids, a non-neoplastic histology, or patients without a follow-up colonoscopy. Among the 331 consecutive patients, a total of 127 patients were excluded for the following reasons: pedunculated type (n=28), colorectal cancer (n=73), carcinoid (n=5), non-neoplastic histology (n=4), and no record of follow-up colonoscopy (n=17). Finally, 204 patients with sessile and flat-type colorectal polyps larger than 20 mm were included in the study ([Fig. 1](#F1){ref-type="fig"}). Clinical, endoscopic, and demographic data were extracted from computerized clinical information system and reviewed retrospectively. The study was approved by the Institutional Review Board of our hospital. All study procedures were conducted in accordance with the International Conference on Harmonisation Good Clinical Practices and the Declaration of Helsinki and its amendments.

Procedures
----------

Colonoscopies were performed after bowel preparation with 4 L polyethylene glycol solution (Colyte; Taejun, Seoul, Korea or Colyte-F or Colonlyte; Dreampharma, Seoul, Korea), by using a single-channel high definition colonoscope (CF Q240L, CF Q240I, CF H260AI, CF Q260AI, or PCF Q260AI; Olympus Optical Co., Tokyo, Japan) and a high-frequency generator with an automatically controlled system (VIO300; ERBE Elektromedizin GmbH, Tubingen, Germany). A translucent cap (D-201-13404 or D-201-14304; Olympus, Optical Co., Ltd., Tokyo, Japan) was mounted on the tip of the colonoscope to control the depth of the mucosal incision and to maintain a satisfactory view during the submucosal dissection.[@B17] Procedures were performed with a patient in a left lateral position under monitored anesthesia sedation. All procedures were performed by 4 experienced gastroenterologists. The endoscopic treatments, including EMR or endoscopic submucosal dissection (ESD), were decided according to the characteristics of the lesion and the preference of operators. EMR was performed using a snare after injecting a solution (normal saline, indigo carmine 0.04%, with or without 1:100000 dilution of epinephrine) into the submucosa.[@B18] Sequential submucosal injection and snare polypectomies were performed for tumor remnants.[@B11] For EMR or snare polypectomies, RotaSnare^®^ (Oval shape, 15/25/35 mm sized; manufactured by Medi-Globe GmbH) was used. ESD was performed with a flex knife (Flex Knife; KD-630L, Olympus, Optical Co., Ltd.) or a dual knife (Dual Knife; KD-650L, Olympus, Optical Co., Ltd.). After spraying and injecting 0.4% indigo carmine dye solution into the submucosa beneath the lesion, a circumferential incision was made with a flex knife set to approximately 2 mm in length. After an additional injection beneath the lesion, the submucosal layer was dissected directly using the flex knife set to approximately 1 mm in length or the dual knife[@B19] to lift it away from the muscularis propria sufficiently. If a residual lesion was detected endoscopically, additional EMR was performed. Resections were defined as follows; en bloc resection was a single piece resection and piecemeal resection was a multiple fragment resection.[@B20] We did not routinely apply argon plasma coagulation or hot biopsy when the post-procedure site was clean. We applied hot biopsy only when the remnant lesion was suspected endoscopically.

Pathological evaluation
-----------------------

Specimens were collected using a basket or by aspiration into the suction channel. For the retrieval of entire sessile polyps located in the right colon, the colonoscope was withdrawn and reinserted as many times as necessary. All specimens were cut into 2-2.5 mm slices and examined microscopically for differentiation, lymphatic invasion, vascular involvement, depth of invasion, the lateral (mucosal) resection margin, and the basal (submucosal) resection margin. The extension of tumor cells to the resected margin was evaluated and graded as complete resection when the lateral and basal resection margins were free of tumor (en bloc resection is essential), incomplete resection when the tumor extended into the lateral or basal margins, or not evaluable when the margins were not evaluable as a result of the artificial effects of coagulation necrosis or multipiece resection.[@B21] We defined negative margin involvement as instances where both lateral mucosal margins of a specimen were free of neoplastic cells. All tumors had negative basal margins. Furthermore, 2 grades of dysplasia (high and low) were recognized. The terms \"arcinoma *in situ*\" and \"intramucosal adenocarcinoma\" were both described as high-grade dysplasia.[@B22]

Definition and follow-up
------------------------

Right-sided colon tumors were defined as those arising from the cecum to the transverse colon. Left-sided colon tumors were defined as those arising from the splenic flexure down to and including the rectosigmoid junction. Rectal tumors were defined as those arising distal to the rectosigmoid junction down to the anus (excluding squamous cell carcinoma).[@B23][@B24]

Postprocedural bleeding (PPB) was divided into immediate PPB (IPPB) and delayed (DPPB). IPPB was defined as bleeding observed immediately after polypectomy and required hemostatic procedures because the bleeding continued for over 60 s. DPPB was defined as bleeding that occurred at the polypectomy site within 30 days of the procedure and required hospitalization or treatment.[@B25] Other delayed adverse events of each patients were collected at the out-paitent clinics.

Patients were followed-up with colonoscopy to evaluate recurrence and residual tumor presence. The interval of surveillance colonoscopy was decided according to the previous guidelines[@B26] and recommendations of our institution. Prior to 2009, however, surveillance colonoscopy was usually recommended after a short interval of less than 12 months. After 2009, surveillance colonoscopy was recommended 12 months after initial treatment, even in cases of piecemeal resection or ESD. If a polyp was detected in follow-up examinations, it was resected if possible. Local recurrence was defined as the presence of adenomatous or carcinomatous tissue on follow-up, confirmed by histology, at the site of prior endoscopic treatment.[@B27] When the local recurrence was suspected, endoscopical mucosal resection was initially tried. If endoscopical treatment was not sufficient, additional surgical treatment was applied.

Statistical analysis
--------------------

Descriptive statistics are provided for the binary and continuous variables using the incidence frequency (%) and mean±standard deviation \[or median (and range) values\]. The chi-square test and Fisher\'s exact test were used to compare binary variables, and the two-sample t-test was used to compare continuous variables. Multivariate logistic regression analysis, adjusted by confounding factors, was performed to discern the contribution of variable factors to inter-group differences in local recurrence (no recurrence vs. recurrence). Two-sided *p*-values were calculated and significance was accepted at the 5% level. All of the statistical analyses were performed with Predictive Analytics SoftWare for Windows, version 18.0.0 (SPSS Inc., Chicago, IL, USA).

RESULTS
=======

Patient characteristics and clinical outcomes at surveillance colonoscopy
-------------------------------------------------------------------------

The baseline clinical, endoscopic, and pathological characteristics are summarized in [Table 1](#T1){ref-type="table"}. Among the 204 patients, there were 128 (62.7%) men and the mean age was 65.1 years. The mean follow-up duration was 44.2±29.5 months. There were 144 flat (70.6%) and 60 sessile polyps (29.4%). The median tumor size was 25 mm. Among the 204 patients, 194 (95.1%) patients were treated with EMR and 10 patients (4.9%) were treated with ESD. The en bloc resection rate was 62.3%, and 77 patients (37.7%) received piecemeal resections. A negative resection margin was observed in 167 cases (81.9%), and 37 cases (18.1%) had a positive lateral margin. Low-grade dysplasia was observed in 100 cases (49%), and high-grade dysplasia was observed in 104 cases (51%). IPPB occurred in 65 patients (31.9%); 59 cases of these occurred during EMR and 6 occurred during ESD. All bleeding was successfully treated using endoscopic hemostasis. There was no case of DPPB. Perforations developed in 4 patients (2.0%); all of these patients were in the EMR group and were successfully treated with clipping.

The median surveillance colonoscopy interval was 9.4 months (1-66 months). A short interval surveillance colonoscopy, with a median of 6.3 months and range of 1-11 months, occurred in 110 patients (53.9%), and 94 patients (46.1%) received a long interval surveillance colonoscopy with a median of 13.6 months and range of 12-66 months. Piecemeal resection patients tended to receive short interval colonoscopies compared to en bloc resection patients (66.2% vs. 46.5%, respectively; *p*=0.006). There were no significant differences in the colonoscopy interval for patients with different treatment methods (*p*=0.112), margin statuses (*p*=0.150), or histologies (*p*=0.068).

During the surveillance colonoscopy, 14 local recurrences (6.9%) were detected. The mean follow-up duration was 47.6± 25.3 months in 14 patients with recurrence and 43.9±29.9 months in 190 patients without recurrence (*p*=0.606). Further details of the patients with local recurrence are given in [Table 2](#T2){ref-type="table"}. Of the local recurrence patients, 7 were located on the right side of the colon. There were 4 patients with sessile-type and 10 patients with flat-type polyps. Three patients developed local recurrences even after an initial en bloc resection with negative resection margin. Mean time to recurrence was 28.4 months (22.7 months with range of 4-54 months in short surveillance interval group vs. 42.8 months with range of 12-82 months in long surveillance interval group, *p*=0.240). Mean size of recurrent lesion was 14.6 mm (11.7 mm in short surveillance interval group vs. 21.8 mm in long surveillance interval group, *p*=0.054). There were 11 patients who were successfully treated with a second endoscopic resection, and 3 patients received surgery.

Risk factors for local recurrence
---------------------------------

The potential risk factors for local recurrence are shown in [Table 3](#T3){ref-type="table"}. In addition, we also assessed the effect of the surveillance colonoscopy interval on local recurrence. Using multivariate analysis, a polyp size greater than 40 mm was shown to be a significant risk factor for the detection of local recurrence at surveillance colonoscopy \[40-50 mm vs. 20-30 mm, odds ratio (OR) 14.22 with 95% confidence interval (CI) 2.10-96.17; *p*=0.006; \>50 mm vs. 20-30 mm, OR 24.25 with 95% CI 3.32-176.88; *p*=0.002\]. However, location, tumor morphology, the resection method, resection status, margin status, and tumor grade were not associated with local recurrence. Furthermore, the surveillance colonoscopy interval had no effect on the rate of local recurrence.

DISCUSSION
==========

The present study has shown that the endoscopic resection of large flat and sessile colorectal polyps generally has a favorable outcome with 6.9% of local recurrence. Polyp larger than 40 mm was an independent risk factor for local recurrence.

EMR is an effective and safe method for the treatment of various colorectal neoplasms.[@B28] Recently, EMR has become the preferred treatment method for large colorectal polyps around the world. This might be due to the favorable outcomes of EMR and low complication rates which have previously been reported. A recent large prospective study of 799 EMR-treated colorectal lesions larger than 20 mm indicated that 98.8% of patients were adenoma-free and did not require surgery 16 months after successful EMR.[@B29] The major complication rates were reported as 5.1-7.9%.[@B6][@B30][@B31] Another recent study reported a 7.9% major complication rate, with 6.3% rate of major bleeding and 1.6% rate of perforation.[@B30] Most bleeding is intra-procedural minor bleeding and is easily managed by endoscopic hemostasis. Although perforation is a serious complication and sometimes requires surgical management, it can be successfully treated with clipping if it is detected during the procedure. In the present study, perforations were detected in 4 patients during the procedure, and these were managed with clipping and medical treatment, thus avoiding surgery. Thus, some operator experience is necessary in order to achieve favorable EMR outcomes with large colorectal polyps, and this can be related to the surveillance colonoscopy interval in practice.

Generally, the recommended adequate surveillance colonoscopy interval is based on the risk of metachronous neoplasms, as predicted by the clinical and histological findings of the index colonoscopy.[@B26][@B32][@B33] However, for large colorectal polyps, the surveillance colonoscopy interval is decided according to the risk of tumor remnants or recurrence. The local recurrence rate after EMR has been reported, ranging from 5% to 45%.[@B2][@B3][@B7] The risk of tumor remnants or recurrence is strongly related to technical factors, such as en bloc resection, the therapeutic method, and the endoscopist\'s experience.[@B34][@B35][@B36][@B37] The en bloc resection rate is reported to be 40-70% for large colorectal polyps.[@B2][@B9][@B17] Previous studies have shown that the local recurrence rate after piecemeal resection is significantly higher than en bloc resection, irrespective of the tumor size or macroscopic features.[@B38] Several current guidelines, recommended a repeat colonoscopy after a short interval (2-6 months) in large sessile and flat colorectal polyps treated with en bloc resection because of the difficulty of complete removal.[@B12][@B13][@B14][@B15] In view of this, some authors preferentially recommend ESD to achieve en bloc resection. In a large prospective cohort study, Saito, et al.[@B39] recently demonstrated that ESD is a feasible technique for treating large superficial colorectal tumors because it provides a higher en bloc resection rate. In this study, a total of 145 lesions were treated with ESD and 228 lesions treated with conventional EMR; there were only 3 cases (2%) of local recurrence in the ESD group, but 14% local recurrence in the EMR group. It is evident that ESD achieved a higher en bloc resection rate than EMR.[@B7] However, ESD needs more operator experience and has a higher complication rate than EMR.[@B7] Thus, ESD cannot be simply applied at primary hospitals treating large colorectal polyps. Furthermore, the present study showed that proper endoscopic treatments, including piecemeal resections, can achieve low rates of local recurrence.

In our study, among the 4 recurred cases in the long interval surveillance colonoscopy group, 3 (75.0%) patients underwent salvage surgeries, possibly implying a possibility that the recurrent lesions were not detected early enough for endoscopic salvage treatment. However, among the 4 recurred cases, only 2 cases were detected in the 1st surveillance colonoscopy. There were several studies to imply that a short surveillance colonoscopy interval could miss tumor local recurrence because of limited regrowth time. In a study from Japan, 572 colorectal tumors were followed-up 3 and 6 months after endoscopic resection, and 28 of the 34 lesions with local recurrence were detected at the first follow-up colonoscopy, while the remaining 6 lesions were detected at the second or a subsequent colonoscopy[@B38] A recent study with follow-up colonoscopy at 3-6 months and 12 months showed a 16.4% rate of late recurrence detection.[@B30] The residual or recurred tumors were treated effectively at follow-up colonoscopy. Thus, it seems reasonable to extend the surveillance colonoscopy interval up to 12 months to allow time for regrowth and reduce the colonoscopy burden. In the present study, among 14 recurred patients, 6 cases (42.9%) were detected in the 2nd or 3rd colonoscopy. Therefore, the interval of a second or third surveillance would also be very important to detect recurred lesions. Consequently, a study of the adequate follow-up interval for the 2nd or 3rd surveillance colonoscopy seems to be mandatory.

The limitations of our study include its retrospective design, and that a number of the practitioners were subject to potential bias. The limited sample size also hindered additional analyses of major interest, such as a finer stratification of the time since endoscopic resection and the separate classification of polyps by individual prognostic factors, such as the number of synchronous lesions and morphological type (e.g., granular or non-granular type laterally spreading tumors), all of which have been found to be strongly related to adenomatous or carcinomatous recurrence after endoscopic resection. A finer stratification of both the time interval and lesion type would be highly desirable so that a clearer safe surveillance period could be delineated for different types of polyp. Another drawback of this study is the single-center study design, which may limit the application of our results to general colonoscopy practice settings. Therefore, further multicenter long term studies are needed in order to confirm our findings.

In conclusion, endoscopic treatment is safe and effective with a favorable long-term outcome for large sessile and flat colorectal polyps. Further prospective study is mandatory to define an adequate interval of surveillance colonoscopy.
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![Flow chart of patients throughout the study. We excluded colorectal tumors with stalks, colorectal cancers, carcinoids, tumors with a non-neoplastic histology, or patients without follow-up colonoscopy. Among the 331 consecutive patients, a total of 127 patients were excluded for the following reasons: pedunculated type (n=28), colorectal cancer (n=73), carcinoid (n=5), non-neoplastic histology (n=4), and no record of follow-up colonoscopy (n=17).](ymj-57-1106-g001){#F1}

###### Baseline Characteristics of Enrolled Patients
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  Characteristics               n=204
  ----------------------------- -------------
  Follow-up duration (months)   44.2±29.5
  Age (yrs)                     65.1±8.2
  Sex (male)                    128 (62.7%)
  Morphology                    
   Flat                         144 (70.6%)
   Sessile                      60 (29.4%)
  Size (range, mm)              
   20-29                        131 (64.2%)
   30-39                        40 (19.6%)
   40-49                        21 (10.3%)
   ≥50                          12 (5.9%)
  Site                          
   Right side                   95 (46.6%)
   Left side                    57 (27.9%)
   Rectum                       52 (25.5%)
  Treatment method              
   EMR                          194 (95.1%)
   ESD                          10 (4.9%)
  Resection                     
   En bloc                      127 (62.3%)
   Piecemeal                    77 (37.7%)
  Resection margin              
   Negative                     167 (81.9%)
   Positive                     37 (18.1%)
  Histological grade            
   LGD                          100 (49.0%)
   HGD                          104 (51.0%)
  Complication                  
   Perforation                  4 (2.0%)
   Bleeding                     65 (31.9%)
  Surveillance colonoscopy      
   Short interval^\*^           110 (53.9%)
   Long interval^†^             94 (46.1%)
  Local recurrence              
   Negative                     190 (93.1%)
   Positive                     14 (6.9%)

EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; LGD, low-grade dysplasia; HGD, high-grade dysplasia.

Categorical variables are presented as n (%) and continuous variables are presented as mean±standard deviation.

^\*^Surveillance colonoscopy within 12 months, ^†^Surveillance colonoscopy after 12 months.

###### Characteristics of Surveillance-Detected Local Recurrences
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       Age   Sex      Initial size (mm)   Initial location   Morphology   Resection   Resection margin   Initial histology and grade   Initial treatment method   1st endoscopic surveillance interval   Time to recurrence (month)   Recurrent lesion size (mm)   Recurrent histology and grade   Additional treatment methods
  ---- ----- -------- ------------------- ------------------ ------------ ----------- ------------------ ----------------------------- -------------------------- -------------------------------------- ---------------------------- ---------------------------- ------------------------------- ------------------------------
  1    69    Male     20                  Left (SC)          Flat         Piecemeal   Negative           TVA with HGD                  EMR                        Short                                  6                            5                            TA                              Removal with biopsy forceps
  2    50    Male     50                  Right (cecum)      Sessile      En bloc     Negative           TVA with LGD                  EMR                        Short                                  11                           5                            TA                              Removal with biopsy forceps
  3    57    Male     40                  Rectum             Flat         Piecemeal   Positive           CIS                           EMR                        Short                                  6                            25                           CIS                             EMR
  4    62    Male     70                  Rectum             Flat         Piecemeal   Positive           TVA with HGD                  EMR                        Long                                   12                           25                           TVA with HGD                    LAR
  5    75    Male     25                  Right (cecum)      Sessile      En bloc     Negative           CIS                           EMR                        Short                                  4                            5                            TA                              Removal with biopsy forceps
  6    58    Female   35                  Right (AC)         Flat         Piecemeal   Negative           TA with LGD                   EMR                        Short                                  6                            5                            TA                              Removal with biopsy forceps
  7    67    Female   30                  Right (TC)         Flat         En bloc     Negative           TA with LGD                   EMR                        Short                                  5                            5                            TA                              Removal with biopsy forceps
  8    58    Female   70                  Right (AC)         Flat         En bloc     Positive           IM cancer                     EMR                        Short                                  29                           9                            TVA with LGD                    Polypectomy
  9    81    Female   40                  Right (AC)         Flat         Piecemeal   Negative           TA with HGD                   ESD                        Short                                  52                           8                            TA                              EMR
  10   70    Male     20                  Right (cecum)      Sessile      Piecemeal   Negative           TA with LGD                   EMR                        Long                                   28                           10                           IS                              RHC
  11   45    Female   33                  Rectum             Sessile      En bloc     Positive           TA with HGD                   EMR                        Long                                   82                           12                           TA with HGD                     EMR
  12   63    Female   60                  Right (cecum)      Flat         Piecemeal   Positive           TVA with HGD                  EMR                        Short                                  54                           10                           TA                              EMR
  13   52    Male     60                  Left (RSJ)         Flat         Piecemeal   Positive           TVA with HGD                  EMR                        Short                                  54                           40                           TVA with HGD                    ESD
  14   54    Female   30                  Left (SC)          Sessile      Piecemeal   Positive           CIS                           EMR                        Long                                   49                           40                           IS                              LAR

TVA, tubulovillous; HGD, high grade dysplasia; CIS, carcinoma *in situ*; IM, intramucosal cancer; TA, tubular adenoma; LGD, low grade dysplasia; IS, invasive adenocarcinoma; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; SC, sigmoid colon; AC, ascending colon; TC, transverse colon; LAR, low anterior resection; RHC, right hemicolectomy; RSJ, rectosigmoid junction.

###### Univariate and Multivariate Regression Analysis of the Factors Associated with Local Recurrence
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  ---------------------------------------------------------------------------------------------------------
                                No recurrence\   Recurrence\     Univariate   Multivariate          
                                (n=190), n (%)   (n=14), n (%)                                      
  ----------------------------- ---------------- --------------- ------------ --------------------- -------
  Age \[median (range), yrs\]   65 (44-82)       60 (45-81)      0.184        0.97 (0.90-1.05)      0.490

  Sex                                                            0.392                              0.608

   Male                         121 (63.7)       7 (50.0)                     1                     

   Female                       69 (36.3)        7 (50.0)                     1.39 (0.39-4.97)      

  Size (mm)                                                      0.001                              

   20-29                        128 (67.4)       3 (21.4)                     1                     

   30-39                        36 (18.9)        4 (28.6)                     5.22 (0.99-27.46)     0.051

   40-49                        18 (9.5)         3 (21.4)                     14.22 (2.10-96.17)    0.006

   ≥50                          8 (4.2)          4 (28.6)                     24.25 (3.32-176.88)   0.002

  Site^\*^                                                       0.773                              

   Right                        87 (45.8)        8 (57.1)                     1                     

   Left                         54 (28.4)        3 (21.4)                     0.32 (0.07-1.54)      0.155

   Rectum                       49 (25.8)        3 (21.4)                     0.29 (0.51-1.66)      0.165

  Morphology                                                     1.000                              0.708

   Flat                         134 (70.5)       10 (71.4)                    1                     

   Sessile                      56 (29.5)        4 (28.6)                     1.32 (0.31-5.58)      

  Method                                                         0.517                              0.544

   EMR                          181 (95.3)       13 (92.9)                    1                     

   ESD                          9 (4.7)          1 (7.1)                      2.14 (0.18-24.74)     

  Resection                                                      0.395                              0.423

   En bloc                      120 (63.2)       7 (50.0)                     1                     

   Piecemeal                    70 (36.8)        7 (50.0)                     1.70 (0.46-6.27)      

  Margin                                                         0.289                              0.373

   Negative                     157 (82.6)       10 (71.4)                    1                     

   Positive                     33 (17.4)        4 (28.6)                     2.01 (0.43-9.34)      

  Grade                                                          0.588                              0.840

   LGD                          92 (48.4)        8 (57.1)                     1                     

   HGD                          98 (51.6)        6 (42.9)                     0.86 (0.20-3.68)      

  Interval^†^                                                    0.266                              0.213

   Short                        100 (52.6)       10 (71.4)                    1                     

   Long                         90 (47.4)        4 (28.6)                     0.42 (0.11-1.65)      
  ---------------------------------------------------------------------------------------------------------

EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; LGD, low-grade dysplasia; HGD, high grade dysplasia; CI, confidence interval.

^\*^Right-sided colon adenomas were defined as those arising from the cecum to the transverse colon. Left-sided colon adenomas were defined as those arising from the splenic flexure down to and including the rectosigmoid junction. Rectal adenomas were defined as those arising distal to the rectosigmoid junction and down to the anus, ^†^Interval refers to the period between the baseline colonoscopy with endoscopic resection and the first surveillance colonoscopy.

[^1]: ^\*^Bun Kim and A Ra Choi contributed equally to this work.
